CSEIX | FARCX | CSEIX / FARCX | |
Total Expense Ratio | 1.10 | 0.93 | 118% |
Annual Report Gross Expense Ratio | 1.10 | 1.02 | 108% |
Fund Existence | 28 years | 30 years | - |
Gain YTD | 4.709 | 2.713 | 174% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 0 | 100000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.3B | 852M | 975% |
Annual Yield % from dividends | 2.72 | 3.63 | 75% |
Returns for 1 year | -1.37 | -6.32 | 22% |
Returns for 3 years | 33.12 | 6.43 | 515% |
Returns for 5 years | 27.14 | -7.60 | -357% |
Returns for 10 years | 55.91 | -16.51 | -339% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
BRWTX | 29.30 | N/A | N/A |
MFS Blended Research Growth Eq R3 | |||
NPSGX | 18.36 | N/A | N/A |
Nicholas Partners Small Cap Gr Instl | |||
JGYCX | 13.52 | N/A | N/A |
JHancock Global Shareholder Yield C | |||
JFNCX | 61.76 | N/A | N/A |
Janus Henderson Global Life Sciences C | |||
RICGX | 67.39 | -0.16 | -0.24% |
American Funds Invmt Co of Amer R6 |